GM Korea announced this week that it will be closing down two of its three production factories in South Korea. The operation will be suspended in the sites starting next week as the company has no more semiconductor parts to use in the cars.
Confirmed plant closure dates
As per Yonhap News Agency, GM Korea will halt all production works in its two plants located in Incheon. The company said that these sites would be closed from April 19 to April 23 and cited chip shortage as the reason for the decision.
"We will continue to work closely with our supply base to find solutions for our suppliers' semiconductor requirements and to mitigate the impact on GM Korea,” the company said in a statement. “Our intent is to make up as much production lost at the plants as possible."
While the factories in Bupyeong, Incheon are affected, GM Korea said that its one other plant in Changwon will remain open. The Incheon plants are actually not operating in their full capacity since the global chip shortage has not been addressed yet despite the efforts of the leading chipmakers.
The affected vehicle units
Now, with GM Korea’s production halt, it was reported that sales for Trailblazer SUV will be affected because this model is being produced at Bupyeong’s plant no. 1. It is clear that the automaker will not be able to deliver new orders for this SUV thus there will be no profit.
At Bupyeong’s plant no. 2, the Malibu sedan and Trax SUV are being made here and due to lack of semiconductor parts, units of these models will not be delivered. All in all, it was said that 6,000 units will not be made during the break so the company is expecting lackluster sales in the coming weeks and maybe even months.
Meanwhile, GM Korea assures customers that it is doing its best to have enough supply of chips for their cars in the following weeks. “We’re in close contact with auto chip suppliers to solve the problem as soon as possible,” Korea Economic Daily quoted a GM Korea official as saying.


Australian Household Spending Dips in December as RBA Tightens Policy
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Japanese Pharmaceutical Stocks Slide as TrumpRx.gov Launch Sparks Market Concerns
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Japan Economy Poised for Q4 2025 Growth as Investment and Consumption Hold Firm
Gold and Silver Prices Slide as Dollar Strength and Easing Tensions Weigh on Metals
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Yen Slides as Japan Election Boosts Fiscal Stimulus Expectations
U.S.-India Trade Framework Signals Major Shift in Tariffs, Energy, and Supply Chains
Singapore Budget 2026 Set for Fiscal Prudence as Growth Remains Resilient 



